[Retracted] Postoperative Effect Observation and Clinical Study of Dahuang Zhechong Pills from Jingui Yaolue in Treating Patients with Early-to-Mid Prostate Cancer Undergoing Radical Resection

Table 1

Between-group comparison of clinical data (n = 49).

Item	Group A	Group B	X^2/t
Mean age (Mean ± SD, years)	61.04 ± 3.86	60.57 ± 3.82	0.683	0.496
Mean course of disease (Mean ± SD, months)	27.42 ± 2.66	26.87 ± 2.31	1.093	0.277
Gleason score (Mean ± SD, points)	4.12 ± 0.99	4.22 ± 1.16	0.459	0.647
KPS score (Mean ± SD, points)	78.47 ± 4.06	78.31 ± 3.71	0.204	0.839
Pathological type
Cystadenocarcinoma	43 (87.76%)	45 (91.84%)	0.446	0.505
Squamous cell carcinoma	1 (2.04%)	2 (4.08%)	0.344	0.558
Neuroendocrine carcinoma	5 (10.20%)	2 (4.08%)	1.385	0.239
Tumor stage			0.176	0.675
Early	32 (65.31%)	30 (61.22%)
Mid-term	17 (34.69%)	19 (38.78%)
Educational degree
College	2 (4.08%)	5 (10.20%)	1.385	0.239
High school	21 (42.86%)	22 (44.90%)	0.041	0.839
Primary school	26 (53.06%)	22 (44.90%)	0.653	0.419
Place of residence			0.165	0.685
Urban area	21 (42.86%)	23 (46.94%)
Rural area	28 (57.14%)	26 (53.06%)